Heartflow (NASDAQ:HTFL) CEO Sells $1,361,500.00 in Stock

Heartflow, Inc. (NASDAQ:HTFL) CEO John C.M. Farquhar sold 38,900 shares of the business’s stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $35.00, for a total value of $1,361,500.00. Following the completion of the sale, the chief executive officer directly owned 457,935 shares of the company’s stock, valued at approximately $16,027,725. The trade was a 7.83% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

• On Wednesday, June 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.50, for a total transaction of $643,017.00.
• On Monday, May 11th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $29.12, for a total transaction of $657,005.44.
• On Friday, April 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $26.72, for a total transaction of $602,856.64.

Heartflow Stock Performance

Shares of Heartflow stock traded up $0.70 during midday trading on Friday, reaching $35.68. 12,523,558 shares of the company’s stock traded hands, compared to its average volume of 1,466,069. Heartflow, Inc. has a 52 week low of $20.13 and a 52 week high of $41.22. The company’s 50 day simple moving average is $30.57 and its 200 day simple moving average is $28.55. The company has a market cap of $3.08 billion and a price-to-earnings ratio of -11.47.

Heartflow (NASDAQ:HTFL) last issued its quarterly earnings data on Thursday, May 14th. The company reported ($0.16) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.08. The business had revenue of $52.59 million during the quarter. Heartflow’s revenue was up 41.3% compared to the same quarter last year. As a group, equities research analysts predict that Heartflow, Inc. will post -0.82 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Essential Partners LLC bought a new stake in Heartflow in the 1st quarter valued at $57,000. Bank of America Corp DE lifted its holdings in shares of Heartflow by 28.8% during the 1st quarter. Bank of America Corp DE now owns 111,702 shares of the company’s stock worth $2,718,000 after acquiring an additional 24,964 shares during the period. Janus Henderson Group PLC lifted its holdings in shares of Heartflow by 152.0% during the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock worth $53,063,000 after acquiring an additional 1,315,416 shares during the period. California State Teachers Retirement System boosted its position in shares of Heartflow by 41.9% during the 1st quarter. California State Teachers Retirement System now owns 29,371 shares of the company’s stock valued at $715,000 after acquiring an additional 8,678 shares in the last quarter. Finally, Royal Bank of Canada increased its stake in Heartflow by 24.4% in the first quarter. Royal Bank of Canada now owns 137,421 shares of the company’s stock valued at $3,343,000 after acquiring an additional 26,912 shares during the period.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on HTFL shares. Wells Fargo & Company raised their price objective on Heartflow from $35.00 to $37.00 and gave the company an “overweight” rating in a research note on Friday, May 15th. JPMorgan Chase & Co. dropped their price target on shares of Heartflow from $40.00 to $35.00 and set an “overweight” rating on the stock in a research report on Thursday, March 19th. Canaccord Genuity Group cut their target price on shares of Heartflow from $43.00 to $37.00 and set a “buy” rating for the company in a research report on Friday, May 15th. Weiss Ratings raised Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, June 12th. Finally, William Blair assumed coverage on Heartflow in a research report on Monday, May 4th. They set an “outperform” rating for the company. Six research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Heartflow has an average rating of “Moderate Buy” and an average price target of $37.00.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.